Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients

Bradley C. Clark; Justin Georgekutty; Charles I. Berul

doi:10.1016/j.jpeds.2015.06.001

Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients

Bradley C. Clark, Justin Georgekutty, Charles I. Berul

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.

Original language	English (US)
Pages (from-to)	757-761.e1
Journal	Journal of Pediatrics
Volume	167
Issue number	3
DOIs	https://doi.org/10.1016/j.jpeds.2015.06.001
State	Published - Sep 1 2015
Externally published	Yes

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1016/j.jpeds.2015.06.001

Cite this

@article{e50f5b2a3e3c4856b51f8c9030cdd247,

title = "Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients",

abstract = "K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.",

author = "Clark, {Bradley C.} and Justin Georgekutty and Berul, {Charles I.}",

note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Inc.",

year = "2015",

month = sep,

day = "1",

doi = "10.1016/j.jpeds.2015.06.001",

language = "English (US)",

volume = "167",

pages = "757--761.e1",

journal = "Journal of Pediatrics",

issn = "0022-3476",

publisher = "Mosby Inc.",

number = "3",

}

TY - JOUR

T1 - Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients

AU - Clark, Bradley C.

AU - Georgekutty, Justin

AU - Berul, Charles I.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.

AB - K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.

UR - http://www.scopus.com/inward/record.url?scp=84940449033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940449033&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2015.06.001

DO - 10.1016/j.jpeds.2015.06.001

M3 - Article

C2 - 26165442

AN - SCOPUS:84940449033

SN - 0022-3476

VL - 167

SP - 757-761.e1

JO - Journal of Pediatrics

JF - Journal of Pediatrics

IS - 3

ER -

Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this